Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CNO Financial (CNO) Cash & Equivalents (2016 - 2025)

CNO Financial (CNO) has disclosed Cash & Equivalents for 15 consecutive years, with $1.2 billion as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents rose 4.6% to $1.2 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $1.2 billion, a 4.6% increase, with the full-year FY2024 number at $1.7 billion, up 113.91% from a year prior.
  • Cash & Equivalents was $1.2 billion for Q3 2025 at CNO Financial, up from $928.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.7 billion in Q4 2024 to a low of $425.0 million in Q1 2023.
  • A 4-year average of $898.1 million and a median of $878.8 million in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 152.76% in 2024, then grew 4.6% in 2025.
  • CNO Financial's Cash & Equivalents stood at $575.7 million in 2022, then soared by 34.53% to $774.5 million in 2023, then skyrocketed by 113.91% to $1.7 billion in 2024, then decreased by 26.46% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for CNO's Cash & Equivalents are $1.2 billion (Q3 2025), $928.2 million (Q1 2025), and $1.7 billion (Q4 2024).